Gastrointestinal Motility Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Subjects who meet the diagnostic criteria of Western medicine as well as Chinese medicine symptoms of spleen and stomach deficiency and cold (weakness) type; 2) Age between 18~80 years old; 3) Have not taken any gastrointestinal prokinetic drugs at least 15 days before receiving treatment and have not participated in other clinical studies; 4) Those who sign the informed consent form inform the purpose process and duration of the clinical study and clearly inform the possible benefits and existing risks and voluntarily participate in the study.
Exclusion criteria
Exclusion criteria: 1) Patients with gastro-oesophageal reflux disease (GERD) irritable bowel syndrome functional diarrhoea abdominal pain constipation etc; 2) Patients with consciousness confusion inability to accurately express uncomfortable symptoms or a history of mental illness; 3) Patients with serious underlying diseases of cardiovascular and cerebrovascular and other systems or accompanied by malignant tumors; 4) Women who are pregnant or preparing to become pregnant lactating women; 5) People with allergies and allergies to multiple drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main symptom score scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome scale;PRO GRP;blood routine examination;The Nepean Dyspepsia Index (NDI);liver and kidney function tests; | — |
Countries
China
Contacts
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine